MSB 2023 - awaiting for Ryoncil approval, page-8

  1. 3,907 Posts.
    lightbulb Created with Sketch. 2751
    New Year musings

    Next week is 90 days since the new potency assay data was sent to CBER.
    I’m making this up- but 90 days turnaround time for feedback is a distinct possibility.
    I’m being presumptuous and presupposing that the BLA resubmission is ready to go - however we await feedback on the IND file submission which was marked as price sensitive.

    Yup - I reckon we are on the CBER clock - a new dawn is about to occur in the scientific medical community- they are also dotting their eyes and crossing their t’s.

    I had a look at the Clbp trial follow up - it was 36 months so no 4 year update coming the week after.



    Have a great 2023

    If you can’t handle the wait- sell


    Will be happy to take them off your hands


    Please listen closely to Sorepocket , Sector and Whytee
    they are brilliant - original material - very positive chaps


    Reg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.41
Change
0.620(34.6%)
Mkt cap ! $3.084B
Open High Low Value Volume
$1.90 $2.48 $1.90 $58.82M 25.68M

Buyers (Bids)

No. Vol. Price($)
3 100915 $2.40
 

Sellers (Offers)

Price($) Vol. No.
$2.41 99 1
View Market Depth
Last trade - 16.12pm 18/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.